Weight loss

An apple cider vinegar drink a day? New study shows it might help weight loss

Retrieved on: 
Wednesday, March 13, 2024

An experimental study, released today, looks into whether apple cider vinegar could be effective for weight loss, reduce blood glucose levels and reduce blood lipids (cholesterol and triglycerides).

Key Points: 
  • An experimental study, released today, looks into whether apple cider vinegar could be effective for weight loss, reduce blood glucose levels and reduce blood lipids (cholesterol and triglycerides).
  • The results suggest it could reduce all three – but it might not be as simple as downing an apple cider vinegar drink a day.

What did they do?

  • A control group consumed an inactive drink (a placebo) made (from lactic acid added to water) to look and taste the same.
  • The study was also double-blinded, which means neither the participants or the scientists involved with collecting the data knew who was in which group.

So, what did they find?

  • After a period of three months apple cider vinegar consumption was linked with significant falls in body weight and body mass index (BMI).
  • On average, those who drank apple cider vinegar during that period lost 6–8kg in weight and reduced their BMI by 2.7–3 points, depending on the dose.
  • The authors also report significant decreases in levels of blood glucose, triglycerides, and cholesterol in the apple cider groups.

Is this good news?

  • Firstly, study participants were aged from 12 to 25, so we can’t say whether the results could apply to everyone.
  • And while the researchers kept records of the participants’ diet and exercise during the study, these were not published in the paper.
  • This could be important and influence results if people who did not lose weight quit due to lack of motivation.


Read more:
Turns out the viral 'Sleepy Girl Mocktail' is backed by science. Should you try it?

Any other concerns?


Apple cider vinegar is acidic and there are concerns it may erode tooth enamel. This can be a problem with any acidic beverages, including fizzy drinks, lemon water and orange juice. To minimise the risk of acid erosion some dentists recommend the following after drinking acidic drinks:

Read more:
Apple cider vinegar: is drinking this popular home remedy bad for your teeth? A dentist explains

Down the hatch?

  • This study provides us with some evidence of a link between apple cider vinegar and weight loss.
  • This would provide more robust evidence that apple cider vinegar could be a useful aid for weight loss.


Evangeline Mantzioris is affiliated with Alliance for Research in Nutrition, Exercise and Activity (ARENA) at the University of South Australia. Evangeline Mantzioris has received funding from the National Health and Medical Research Council, and has been appointed to the National Health and Medical Research Council Dietary Guideline Expert Committee.

HIMALAYA TECHNOLOGIES PARTNERS WITH RENOVI! TO TARGET MEDICAL TOURISM MARKET IN CARIBBEAN; ADDS CEO TO ADVISORY BOARD

Retrieved on: 
Monday, March 11, 2024

Additionally, the Company has appointed Renovi!’s CEO, David Burns, Ph.D., to its Advisory Board to guide its entry into this multi-billion dollar market, assist on mergers and acquisitions including a potential combination of Renovi!

Key Points: 
  • Additionally, the Company has appointed Renovi!’s CEO, David Burns, Ph.D., to its Advisory Board to guide its entry into this multi-billion dollar market, assist on mergers and acquisitions including a potential combination of Renovi!
  • The availability of the newest medical technologies and the cheaper cost of treatment in emerging nations are key market drivers enhancing market growth.
  • reinvents traditional outpatient rehabilitation by offering patients a “recovery vacation” at an upscale, beachfront medical resort with healthy diet, exercise, community and exceptional medical care.
  • The Dominican Republic is uniquely positioned as a medical tourism destination because of its low costs, proximity to the U.S., a well-established tourism infrastructure, and tax incentives for tourism investments.

LifeMD Reports Fourth Quarter 2023 Results

Retrieved on: 
Monday, March 11, 2024

NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today reported financial results for the three and twelve months ended December 31, 2023.   

Key Points: 
  • Conference call begins at 4:30 p.m. Eastern time today
    NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today reported financial results for the three and twelve months ended December 31, 2023.
  • “2023 was a record-setting year for LifeMD, characterized by sharp increases in revenue, telehealth subscribers and profitability.
  • Telehealth revenue increased 90% versus the year-ago period and 28% sequentially versus the third quarter of 2023.
  • The number of weight management subscribers exceeded 22,000 as of year-end 2023, a net gain of approximately 12,000 subscribers sequentially versus the third quarter of 2023.

NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Monday, March 11, 2024

--On February 26, 2024, announced that it had entered into the Agreement and Plan of Merger with Atlas Neon Parent, Inc., and Atlas Neon Merger Sub, Inc.--

Key Points: 
  • The combination of NGM707 and pembrolizumab was generally well-tolerated at all four doses (200, 600, 1200, 1800 mg) of NGM707.
  • Additional details can be found in NGM Bio’s recent filings with the United States Securities and Exchange Commission (SEC).
  • NGM Bio anticipates that the Offer and the Merger contemplated under the Merger Agreement will be consummated in the second quarter of 2024.
  • If the Merger is effected, NGM Bio’s common stock will be delisted from The Nasdaq Stock Market LLC and NGM Bio will be privately held.

Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates

Retrieved on: 
Friday, March 8, 2024

JERUSALEM, March 08, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides, today reported financial results and key business updates for the fourth quarter and year ended December 31, 2023.

Key Points: 
  • JERUSALEM, March 08, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides, today reported financial results and key business updates for the fourth quarter and year ended December 31, 2023.
  • Following our December 2023 financing, we expect to have sufficient cash to fund operations through the first half of 2025,” said Miranda Toledano, CEO of Entera.
  • Financial Results for the year Ended December 31, 2023
    As of December 31, 2023, Entera had cash and cash equivalents of $11.0 million.
  • Operating expenses for year ended December 31, 2023 were $8.9 million, as compared to $13.0 million for the year ended December 31, 2022.

MaNaDr's Weight Management Program Makes Waves at World Obesity Day Walk 2024 in Singapore

Retrieved on: 
Friday, March 8, 2024

MaNaDr, the gold event sponsor, believes more than 500 attendees visited its’ booth to inquire about the weight management program.

Key Points: 
  • MaNaDr, the gold event sponsor, believes more than 500 attendees visited its’ booth to inquire about the weight management program.
  • “We were thrilled by the enthusiasm and level of engagement surrounding weight management at the event,” said MaNaDr chief executive officer and co-founder Dr. Siaw Tung Yeng.
  • Second, all our doctors in the program are certified family physicians with Singapore’s latest Basic Obesity Management Accreditations.
  • These activities are part of the global World Obesity Day, an annual event started in 2015 to increase worldwide awareness of obesity.

Sharps Technology and Roncadelle Operations Sign Worldwide Sales and Distribution Agreement for their Innovative Portfolio of Safe Technology Drug Delivery Systems

Retrieved on: 
Thursday, March 7, 2024

The agreement, signed on March 4, 2024, lays the groundwork for further collaboration between Sharps and Roncadelle to develop and manufacture next-generation drug delivery products.

Key Points: 
  • The agreement, signed on March 4, 2024, lays the groundwork for further collaboration between Sharps and Roncadelle to develop and manufacture next-generation drug delivery products.
  • “We believe that this is just the beginning of Sharps’ collaboration with Roncadelle.
  • “This alliance underscores our unwavering commitment to innovation and excellence, reshaping standards within the global healthcare landscape.”
    Sharps Technology specializes in the development and manufacturing of innovative drug delivery systems.
  • As part of the cooperative agreement, Sharps and Roncadelle intend to collaborate on the development of new drug delivery products.

Teladoc Health Expands Obesity & Weight Management Capabilities

Retrieved on: 
Thursday, March 7, 2024

The multidisciplinary care model is designed by clinicians experienced in obesity medicine and delivered with a tailored approach to weight management.

Key Points: 
  • The multidisciplinary care model is designed by clinicians experienced in obesity medicine and delivered with a tailored approach to weight management.
  • Clients can provide their populations with comprehensive and integrated clinical care, that also addresses wellbeing, mental health and social drivers of health in a personalized manner,” said Dr. Vidya Raman-Tangella, Teladoc Health Chief Medical Officer.
  • The Comprehensive Weight Management solution is customized for health plans and employers to meet the needs of their populations and reduce the cost of care for obesity-related medical expenses by going beyond care coordination to deliver:
    An evidence-based, personally tailored approach inclusive of comprehensive support from providers experienced in obesity management, health coaching, medical nutrition therapy, and integrated, highly accessible mental health support.
  • More information on Teladoc Health’s obesity and weight management programs can be found here .

Academy of Nutrition and Dietetics Promotes Tool to Help Diagnose Malnutrition in Hospitalized Adults

Retrieved on: 
Thursday, March 7, 2024

Many of these patients went undiagnosed because health care providers had no universally accepted tool to check, until now.

Key Points: 
  • Many of these patients went undiagnosed because health care providers had no universally accepted tool to check, until now.
  • A malnutrition tool, referred to as AAIM, can help registered dietitian nutritionists (RDNs) accurately diagnose malnutrition, according to two scientific papers from the Academy of Nutrition and Dietetics.
  • Armed with this tool and the accurate assessment of malnutrition, RDNs can provide medical nutrition therapy to improve patient outcomes and reduce health care costs.
  • Details about the AAIM tool can be found in the paper Predictive validity of the Academy of Nutrition and Dietetics/American Society for Parenteral and Enteral Nutrition indicators (AAIM) to diagnose malnutrition tool in hospitalized adults: a cohort study , now in press in The American Journal of Clinical Nutrition.

Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Retrieved on: 
Wednesday, March 6, 2024

In the fourth quarter of 2023, Wave initiated dosing in RestorAATion-1, which resulted in a $20 million milestone payment from GSK.

Key Points: 
  • In the fourth quarter of 2023, Wave initiated dosing in RestorAATion-1, which resulted in a $20 million milestone payment from GSK.
  • Revenue was $29.1 million for the fourth quarter of 2023 as compared to $1.2 million in the prior year quarter.
  • Net loss was $16.3 million for the fourth quarter of 2023 as compared to $43.7 million in the prior year quarter.
  • ET to review the fourth quarter and full year 2023 financial results and pipeline updates.